Corporate Profile

Scope of Business

Development, manufacture, and marketing of pharmaceutical products, such as injection agents, internal drugs, drugs for external use, and diagnostic products.

Business Domain

Clients People seeking good health, those involved in medical services and pharmaceuticals
Products and Services Medical care for women, in vitro diagnostics, acute medical care products and curative medicine (injection agents), and information regarding pharmaceuticals and health
Core Competency Research and development, manufacture, and marketing in selected disease domains

Passionate about quality of products, people, and management

Hard-working employees and partners

Corporate Data

Head Office

5-7 Sanban-cho, Chiyoda-ku, Tokyo 102-0075, Japan
Tel: +81-3-3556-3344; Fax: +81-3-3556-4455
Established April 1965
Capital ¥3,799 million
Stock Listings Tokyo Stock Exchange, First Section
Fiscal Year-End September
Representatives Hirofumi Imai, Chairman and Representative Director
Eiji Takemasa, President & CEO
Board Members Takayuki Kasai, Vice President
Masayuki Kozawa, Director
Seiichi Inoue, Director
Tadahiro Kozawa, Outside Director
Masayuki Uchida, Outside Director
Hidekazu Tanaka, Outside Director
Keiji Hirai, Outside Director
Kenichi Tokunaga, Audit & Supervisory Board Member
Fujiaki Mimura, Outside Audit & Supervisory Board Member
Akira Sato, Outside Audit & Supervisory Board Member
Office Locations Head Office: Tokyo
Branch Offices: Hokkaido-tohoku, Kanto No. 1, Kanto No. 2, Nagoya, Keiji-hokuriku, Kansai, Chushikoku, Fukuoka
Plant: Toyama
R&D Facility: Toyama (Toyama Research and Development Center)
Group Company Overseas OLIC (Thailand) Limited
Number of Employees Consolidated: 1,455 (As of September 30, 2016)
・Fuji Pharma Co., Ltd.: 691
・OLIC (Thailand) Limited: 764